Braun RP - Search Results

1

Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?

Haueis SA, Kränzlin P, Mangana J, Cheng PF, Urosevic-Maiwald M, Braun RP, Levesque MP, Dummer R, Goldinger SM. Haueis SA, et al. Among authors: braun rp. Melanoma Res. 2017 Jun;27(3):231-237. doi: 10.1097/CMR.0000000000000338. Melanoma Res. 2017. PMID: 28099366 Free article. Clinical Trial.

2

Prognostic relevance of lactate dehydrogenase and serum S100 levels in stage IV melanoma with known BRAF mutation status.

Frauchiger AL, Mangana J, Rechsteiner M, Moch H, Seifert B, Braun RP, Dummer R, Goldinger SM. Frauchiger AL, et al. Among authors: braun rp. Br J Dermatol. 2016 Apr;174(4):823-30. doi: 10.1111/bjd.14347. Epub 2016 Mar 2. Br J Dermatol. 2016. PMID: 26659191

3

Sarcoid-like reactions in patients receiving modern melanoma treatment.

Dimitriou F, Frauchiger AL, Urosevic-Maiwald M, Naegeli MC, Goldinger SM, Barysch M, Franzen D, Kamarachev J, Braun R, Dummer R, Mangana J. Dimitriou F, et al. Melanoma Res. 2018 Jun;28(3):230-236. doi: 10.1097/CMR.0000000000000437. Melanoma Res. 2018. PMID: 29485531 Free PMC article.

4

Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanoma.

Mangana J, Dimitriou F, Braun R, Ludwig S, Dummer R, Barysch MJ. Mangana J, et al. Melanoma Res. 2019 Dec;29(6):648-654. doi: 10.1097/CMR.0000000000000593. Melanoma Res. 2019. PMID: 30870270 Free article.

5

Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma.

Dimitriou F, Matter AV, Mangana J, Urosevic-Maiwald M, Micaletto S, Braun RP, French LE, Dummer R. Dimitriou F, et al. Among authors: braun rp. J Immunother. 2019 Jan;42(1):29-32. doi: 10.1097/CJI.0000000000000236. J Immunother. 2019. PMID: 29939877 Free article.

6

Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma.

Dimitriou F, Mangana J, Micaletto S, Braun RP, Dummer R. Dimitriou F, et al. Among authors: braun rp. Melanoma Res. 2019 Feb;29(1):107-108. doi: 10.1097/CMR.0000000000000544. Melanoma Res. 2019. PMID: 30557221 Free article. No abstract available.

7

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland.

Mangana J, Cheng PF, Kaufmann C, Amann VC, Frauchiger AL, Stögner V, Held U, von Moos R, Michielin O, Braun RP, Levesque MP, Goldinger SM, Dummer R. Mangana J, et al. Among authors: braun rp. Melanoma Res. 2017 Aug;27(4):358-368. doi: 10.1097/CMR.0000000000000359. Melanoma Res. 2017. PMID: 28509765 Free PMC article.

8

Update on adjuvant melanoma therapy.

Dimitriou F, Braun RP, Mangana J. Dimitriou F, et al. Among authors: braun rp. Curr Opin Oncol. 2018 Mar;30(2):118-124. doi: 10.1097/CCO.0000000000000432. Curr Opin Oncol. 2018. PMID: 29256902 Free article. Review.

9

Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.

Ludwig SV, F Cheng P, Mangana J, Braun R, Dummer R, Koelblinger P. Ludwig SV, et al. Eur J Dermatol. 2020 Dec 1;30(6):699-709. doi: 10.1684/ejd.2020.3929. Eur J Dermatol. 2020. PMID: 33459260

10

Critical aspects to achieve a high-quality melanoma clinic.

Dummer R, Ramelyte E, Levesque M, Goldinger SM, Braun RP. Dummer R, et al. Among authors: braun rp. Curr Opin Oncol. 2017 Mar;29(2):145-150. doi: 10.1097/CCO.0000000000000357. Curr Opin Oncol. 2017. PMID: 28027104 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters